Effect of thiols exported by cancer cells on the stability and growth-inhibitory activity of Pt(IV) complexes

Journal of Cancer Research and Clinical Oncology

Volumn 125, Issue 12, 1999, Pages 690-696

  Kratochwil, Nicole A ^a,b   Bednarski, Patrick J ^a,c  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Cancer cell lines; Metabolism; Pt(IV) complexes; Stability; Thiol release

Indexed keywords

CYTOTOXIC AGENT; PLATINUM COMPLEX; THIOL;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL KINETICS; CYTOTOXICITY; DRUG ACTIVATION; DRUG EFFECT; DRUG STABILITY; GLIOBLASTOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; TIMED DRUG RELEASE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL DIVISION; CULTURE MEDIA; CULTURE MEDIA, CONDITIONED; DRUG STABILITY; EXTRACELLULAR SPACE; HUMANS; KINETICS; ORGANOPLATINUM COMPOUNDS; SULFHYDRYL COMPOUNDS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0032734787     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050335     Document Type: Article

References (36)

1. Andrews PA (1994) Mechanism of acquired resistance to cisplatin. Cancer Treat Res 73:217
2. Bannai S, Tsukeda H (1979) The export of glutathione from human diploid cells in culture. J Biol Chem 254:3444
3. Beale PJ, Kelland LR, Judson IR (1996) Platinum agents in the treatment of cancer. Exp Opin Invest Drugs 5:681
4. 2 and their reduction products with PM2 DNA. Biochemistry 23:4817
5. Chaney SG (1995) The chemistry and biology of platinum complexes with the 1,2-diaminocyclohexane carrier ligand (Review). Int J Oncol 6:1291
6. Chaney SG, Wyrick S, Till GK (1990) In vitro biotransformations of tetrachloro(d,1-trans)-1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in rat plasma. Cancer Res 50:4539
7. Choi S, Filotto C, Bisanzo M, Delaney S, Lagasee D, Whitworth JL, Jusko A, Li C, Wood NA, Willingham J, Schwenker A, Spaulding K (1998) Reduction and anticancer activity of platinum(IV) complexes. Inorg Chem 37:2500
8. Dethmers JK, Meister A (1981) Glutathione export by human lymphoid cells: depletion of glutathione by inhibition of its synthesis decreases export and increases sensitivity to irradiation. Proc Natl Acad Sci USA 78:7492
9. Eastman A (1987) Glutathione-mediated activation of anticancer platinum(IV) complexes. Biochem Pharmacol 36:4177
10. Ellis LT, Er HM, Hambley TW (1995) The influence of the axial ligands of a series of platinum(IV) anti-cancer complexes on their reduction to platinum(II) and reaction with DNA. Aust J Chem 48:793
11. Gibbons GR, Wyrick S, Chaney SG (1989) Rapid reduction of tetrachloro(D,L-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) in RPMI 1640 tissue culture medium. Cancer Res 49:1402
12. Griffith OW, Novogrodsky A, Meister A (1979) Translocation of glutathione from lymphoid cells that have markedly different γ-glutamyltranspeptidase activity. Proc Natl Acad Sci USA 76:2249
13. Hartley FR (1973) The chemistry of platinum and palladium. Applied Science, London, p 315
14. Kelland LR, Murrer BA, Abel G, Giandomenico CM, Mistry P, Harrap KR (1992) Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines. Cancer Res 52:822
15. Kelland LR, Abel G, Mc Keage MJ, Jones M, Goddard PM, Valenti M, Murrer BA, Harrap KR (1993) Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug. Cancer Res 53:2581
16. Kelly SL, Rozencweig M (1989) Resistance to platinum compounds: mechanism and beyond. Eur J Cancer Clin Oncol 25:1135
17. Kido Y, Khokhar AR, Siddik ZH (1994) Glutathione-mediated modulation of tetraplatin activity against sensitive and resistant tumor cells. Biochem Pharmacol 47:1635
18. Kratochwil NA, Bednarski PJ, Mrozek H, Vogler A, Nagle JK (1996a) Photolysis of an iodoplatinum(IV) diamine complex to cytotoxic species by visible light. Anti-Cancer Drug Des 11:155
19. 2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro. J Med Chem 39:2499
20. Kratochwil NA, Guo Z, Murdoch PdelS, Parkinson JA, Bednarski PJ, Sadler PJ (1998) Electron-transfer-driven trans ligand labilization: a novel activation mechanism for Pt(IV) anticancer complexes. J Am Chem Soc 120:8253
21. Kratochwil NA, Parkinson JA, Bednarski PJ, Sadler PJ (1999) Nucleotide platination induced by visible light. Angew Chem Int Ed Engl 38:1460
22. Kratochwil NA, Bednarski PJ (1999) "Relationships between reduction properties and cancer cell growth inhibitory activities of cis-Dichloro- and cis-Diiodo-Pt(IV)-ethylenediamines." Arch Pharm Pharm Med Chem (in press)
23. Newton GL, Aguilera JA, Fahey RC, Ward JF, Radkowsky AE, Kosower EM (1992) para-Sulfobenzoyloxybromobimane: a new membrane-impermeable reagent useful for the analysis of thiols and their export from cells. Anal Biochem 201:30
24. Pendyala L, Cowens JW, Chheda GB, Dutta SP, Creaven PJ (1988) Identification of cis-dichloro-bis-isopropylamine platinum(II) as a major metabolite of iproplatin in humans. Cancer Res 48:3533
25. Pendyala L, Wash JR, Huq MM, Arakali AV, Cowens JW, Creaven PJ (1989) Uptake and metabolism of iproplatin in murine L1210 cells. Cancer Chemother Pharmacol 25:15
26. Pendyala L, Creaven PJ, Perez R, Zdanowicz JR, Raghavan D (1995) Intracellular glutathione and cytotoxicity of platinum complexes. Cancer Chemother Pharmacol 36:271
27. Prezioso JA, Shields D, Wang N, Rosenstein M (1994) Role of γ-glutamyltranspeptidase-mediated glutathione transport on the radiosensitivity of B16 melanoma variant cell lines. Int J Radiat Oncol Biol Phys 30:373
28. Raynaud FI, Odell DE, Kelland LR (1996) Intracellular metabolism of the orally active platinum drug JM216: influence of glutathione levels. Br J Cancer 74:380
29. Reile H, Birnböck H, Bernhardt G, Spruß Th, Schönenberger H (1990) Computerized determination of growth kinetic curves and doubling times from cells in microculture. Anal Biochem 187:262
30. Rischin D, Ling V (1996) Ormaplatin resistance is associated with decreased accumulation of its platinum(II) analog, dichloro(D,L-trans)1,2-diaminocyclohexane-platinum(II). Br J Cancer 74:590
31. 3]Cl), with purine nucleosides and nucleotides results in formation of platinum(II) as well as platinum(IV) complexes. J Inorg Chem 52:263
32. Shi T, Berglund J, Elding LI (1996) Kinetics and mechanism for reduction of trans-dichlorotetracyanoplatinate(IV) by thioglycolic acid, L-cysteine, DL-penicillamine, and glutathione in aqueous solution. Inorg Chem 35:3498
33. Talman EG, Brüning W, Reedijk J, Spek AL, Veldman N (1997) Crystal and molecular structures of asymmetric cis- and trans- platinum(II/IV) compounds and their reactions with DNA fragments. Inorg Chem 36:854
34. Veer JL van der, Peters AR, Reedijk (1986) Reaction products from platinum(IV) amine compounds and 5′-GMP are mainly bis(5′-GMP)platinum(II) amine adducts. J Inorg Chem 26:137
35. Versantvoort CHM, Bagrij T, Wright KA, Twentyman PR (1995) On the relationship between the probenecid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance-associated protein (MRP). Int J Cancer 63:855
36. Zaman GJR, Lankelma J, Van Tellingen O, Beijnen J, Dekker H, Paulusma C, Oude Elferink RPJ, Baas F, Borst P (1995) Role of glutathione in the export of compounds from cells by multidrug-resistance-associated protein. Proc Natl Acad Sci USA 92:7690